tradingkey.logo

DIH Holding US Inc

DHAI

0.250USD

+0.001+0.24%
Market hours ETQuotes delayed by 15 min
8.71MMarket Cap
LossP/E TTM

DIH Holding US Inc

0.250

+0.001+0.24%
More Details of DIH Holding US Inc Company
DIH Holding US, Inc. is a global robotics and virtual reality (VR) technology provider in the rehabilitation and human performance industry. The Company offers an integrated solution for the entire continuum of care and multiple markets, including hospitals, clinics, research and home. Its rehabilitation hospitals and outpatient clinics offering solutions include ArmeoPower, ArmeoSpring, ArmeoSpring Pro, ArmeoSenso, Erigo, Lokomat, SafeGait 360 by Gorbel, RYSEN, Andago, C-Mill, and HocoNet. Its Research & Academia offering solutions include GRAIL, CAREN Extended, M-Gait, and D-Flow. The ArmeoSpring Pro is a cutting-edge medical device designed to bring upper limb rehabilitation to the next level. ArmeoPower guides the initial phases of arm and hand function recovery. ArmeoSpring supports the recovery of arm and hand functions. ArmeoSenso is a sensor-based solution for arm function recovery. HocoNet is a software platform connecting product portfolio across the entire continuum of care.
Company Info
Ticker SymbolDHAI
Company nameDIH Holding US Inc
IPO dateFeb 09, 2024
CEOMr. Jason Chen
Number of employees192
Security typeOrdinary Share
Fiscal year-endFeb 09
Address77 Accord Park Drive, Suite D-1
CityNORWELL
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code02061
Phone18779442200
Websitehttps://www.dih.com/
Ticker SymbolDHAI
IPO dateFeb 09, 2024
CEOMr. Jason Chen
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Max Baucus
Mr. Max Baucus
Independent Director
Independent Director
52.82K
--
Mr. Dennis Streppa
Mr. Dennis Streppa
Director
Director
--
--
Mr. Jason Chen
Mr. Jason Chen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lynden Bass
Ms. Lynden Bass
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. F. Samuel Eberts, III
Mr. F. Samuel Eberts, III
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Max Baucus
Mr. Max Baucus
Independent Director
Independent Director
52.82K
--
Mr. Dennis Streppa
Mr. Dennis Streppa
Director
Director
--
--
Mr. Jason Chen
Mr. Jason Chen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lynden Bass
Ms. Lynden Bass
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. F. Samuel Eberts, III
Mr. F. Samuel Eberts, III
Director
Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q3
FY2025Q1
FY2024
FY2024Q1
FY2023
FY2023Q4
FY2023Q1
FY2022
FY2021
By BusinessUSD
Name
Revenue
Proportion
Devices
11.70M
77.53%
Services
3.11M
20.61%
Other
280.00K
1.86%
By RegionUSD
Name
Revenue
Proportion
Europe, Middle East and Africa
8.70M
57.63%
Americas
3.49M
23.12%
Asia Pacific
2.91M
19.25%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Devices
11.70M
77.53%
Services
3.11M
20.61%
Other
280.00K
1.86%
Shareholding Stats
Updated: Wed, Jul 16
Updated: Wed, Jul 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
DIH Technology Ltd
29.76%
Five Narrow Lane LP
9.92%
ATAC Sponsor LLC
9.49%
Armistice Capital LLC
4.39%
OrbiMed Advisors, LLC
4.05%
Other
42.40%
Shareholders
Shareholders
Proportion
DIH Technology Ltd
29.76%
Five Narrow Lane LP
9.92%
ATAC Sponsor LLC
9.49%
Armistice Capital LLC
4.39%
OrbiMed Advisors, LLC
4.05%
Other
42.40%
Shareholder Types
Shareholders
Proportion
Corporation
49.17%
Hedge Fund
4.47%
Private Equity
4.05%
Investment Advisor/Hedge Fund
3.37%
Individual Investor
0.45%
Investment Advisor
0.15%
Research Firm
0.12%
Other
38.24%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
52
29.24M
61.76%
+6.73M
2025Q1
52
29.23M
61.74%
+6.70M
2024Q4
62
19.61M
55.51%
-8.90M
2024Q3
61
19.55M
48.67%
-10.15M
2024Q2
76
20.38M
54.94%
-13.59M
2024Q1
69
19.22M
59.72%
-10.42M
2023Q4
63
2.69M
47.25%
-13.85M
2023Q3
63
5.23M
86.09%
-12.71M
2023Q2
61
6.36M
105.17%
-11.39M
2023Q1
60
6.20M
30.61%
-12.95M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
DIH Technology Ltd
14.09M
29.76%
--
--
Jan 07, 2025
Five Narrow Lane LP
4.70M
9.92%
+4.62M
+5991.91%
Feb 03, 2025
ATAC Sponsor LLC
4.49M
9.49%
+105.63K
+2.41%
Jan 07, 2025
Armistice Capital LLC
2.08M
4.39%
+2.08M
--
Mar 31, 2025
OrbiMed Advisors, LLC
1.92M
4.05%
+1.92M
--
Mar 31, 2025
The Vanguard Group, Inc.
1.25M
2.65%
+701.91K
+127.28%
Mar 31, 2025
Geode Capital Management, L.L.C.
239.34K
0.51%
+115.00
+0.05%
Mar 31, 2025
Eberts (F Samuel III)
105.63K
0.22%
--
--
Jan 07, 2025
Sugar Maple Asset Management, LLC
62.90K
0.13%
+62.90K
--
Mar 31, 2025
Virtu Americas LLC
58.63K
0.12%
+58.63K
--
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
SPAC and New Issue ETF
0.01%
iShares Micro-Cap ETF
0%
SPAC and New Issue ETF
Proportion0.01%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI